Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis.

Sexually transmitted infections - 1 Feb 2018

Horner Patrick, Ingle Suzanne M, Garrett Frederick, Blee Karla, Kong Fabian, Muir Peter, Moi Harald

Abstract excerpt

BACKGROUND: There is increasing evidence that azithromycin 1 g is driving the emergence of macrolide resistance in Mycoplasma genitalium worldwide. We undertook a meta-analysis of M. genitalium treatment studies using azithromycin 1 g single dose and azithromycin 500 mg on day 1 then 250 mg daily for 4 days (5-day regimen) to determine rates of treatment failure and resistance in both regimens. METHODS: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Azithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Bacterial

Share to Drug Resistance, Bacterial

Share to Macrolides

Share to Mycoplasma genitalium

Share to Mycoplasma Infections

Share to Treatment Failure

Source

Identifiers

PMID: 28717050
DOI: 10.1136/sextrans-2016-053060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis.PMID 28717050Read ↗

Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.Semantic proximity Read ↗

Implementation of Mycoplasma genitalium Diagnostics with Macrolide-Resistance Detection Improves Patient Treatment Outcomes in BulgariaSemantic proximity Read ↗

Azithromycin Treatment Failure in Mycoplasma genitalium –Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide ResistanceSemantic proximity Read ↗

Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin.Semantic proximity Read ↗

Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt AnalysisSemantic proximity Read ↗

Frequency and Correlates of Mycoplasma genitalium Antimicrobial Resistance Mutations and Their Association With Treatment Outcomes: Findings From a National Sentinel Surveillance Pilot in England.Semantic proximity Read ↗

Molecular basis of antimicrobial resistance in Mycoplasma genitalium.Semantic proximity Read ↗

Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019.Semantic proximity Read ↗

Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China.Semantic proximity Read ↗

Low prevalence of macrolide resistance in Mycoplasma genitalium infections in a cohort of pregnant women living with human immunodeficiency virus.Semantic proximity Read ↗

Antibiotic Resistance and Genotypes of Mycoplasma genitalium during a Resistance-Guided Treatment Regime in a German University HospitalSemantic proximity Read ↗

Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.